There will be a major change to Medicare Part D in 2025 with the “doughnut hole,” or coverage gap going away. The maximum out-of-pocket cost for Part D prescriptions in 2025 will be $2,000.
Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from approving it, though the generic’s launch faces other legal roadblocks. U.S. District Judge Dabney Friedrich in Washington, D.C., in an order made public on Tuesday, said the U.S. ...
The average employer-sponsored health insurance premium for US families rose 7% this year – same as last year, according to the annual KFF survey of 2,100 companies.
On September 30, Governor Gavin Newsom concluded review and action on more than 1,200 bills sent to his desk as part of the 2024 regular legislative session. This year represented many major legislative wins for the California Chamber of Commerce working on behalf of California employers.
In its estimates released Tuesday, CBO said 12.5 million Medicare beneficiaries would qualify for the medications beginning in 2026, and 2 percent would be expected to use the drugs in the first year.
Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore chain’s ongoing turnaround strategy amid a rocky fiscal 2024. The company will close 500 stores next year as it works to improve its cash flow. The closure ...